TWICE-IRI
Phase 3 Unknown
202 enrolled
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
Phase 3 Unknown
537 enrolled
TRAILOCLORI01
Phase 3 Unknown
112 enrolled
INTEGRATEIIa
Phase 3 Unknown
250 enrolled
GEMFOX
Phase 3 Unknown
400 enrolled
CAMELLIA
Phase 3 Unknown
280 enrolled
IMPALA
Phase 3 Unknown
540 enrolled
Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin
Phase 3 Unknown
360 enrolled
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
Phase 3 Unknown
280 enrolled
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Phase 3 Unknown
700 enrolled
FUMANCE
Phase 3 Unknown
156 enrolled
FEVEX
Phase 3 Unknown
745 enrolled
Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery
Phase 3 Unknown
230 enrolled
Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer
Phase 3 Unknown
230 enrolled
M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
Phase 3 Unknown
387 enrolled
APREMEC
Phase 3 Unknown
3,000 enrolled
A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer
Phase 3 Unknown
700 enrolled
5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
Phase 3 Unknown
568 enrolled
Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
Phase 3 Unknown
312 enrolled
Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
Phase 3 Unknown
Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
Phase 3 Unknown
336 enrolled
Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
Phase 3 Unknown
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Phase 3 Unknown
1,404 enrolled
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
Phase 3 Unknown
340 enrolled
TRICK
Phase 3 Unknown
60 enrolled
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
Phase 3 Unknown
200 enrolled
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 3 Unknown
PHRAC
Phase 3 Unknown
600 enrolled
ChemoSensMM
Phase 3 Unknown
360 enrolled
TOP
Phase 3 Unknown
500 enrolled
Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
Phase 3 Unknown
1,200 enrolled
Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC
Phase 3 Unknown
381 enrolled
PANVACâ„¢-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
Phase 3 Unknown
250 enrolled